The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Survival of Blacks and Whites After a Cancer Diagnosis
Abstract
CONTEXT: In recent years a theory that cancer biology is different in blacks and whites has gained prominence in reaction to epidemiologic observations that blacks have poorer survival than whites, even when diagnosed with cancer of similar severity. Yet, few studies have evaluated whether lower-quality treatment and shorter overall life expectancy due to a greater burden of other illnesses may explain the survival discrepancy. OBJECTIVE: To estimate the magnitude of overall and cancer-specific survival differences between blacks and whites who receive comparable treatment for similar-stage cancer. DATA SOURCES: We searched MEDLINE for English-language articles published from 1966 to January 2002 that reported on overall survival for black and white patients treated similarly for cancer. STUDY SELECTION: The abstracts or titles for 891 citations were independently examined by 2 authors. The full text was retrieved if the abstract mentioned both black and white patients, made some comment regarding either similarity of treatment received or presented an analysis based on the treatment received, and commented on survival. Studies were included if they included data for at least 10 black and 10 white patients; specified the cohort ascertainment method and what measures were undertaken to minimize loss to follow-up; summarized survival of both blacks and whites using actuarial measures; presented outcomes within stage, adjusted for stage, or based on cohorts with balanced stage distributions; and specified that blacks and whites in the study received similar treatment. We identified 89 unique cohorts in 54 articles that met our inclusion criteria. DATA EXTRACTION: Overall survival rates and hazard ratios (HRs) for death for blacks relative to whites were calculated. These were subsequently adjusted for rates of death due to causes other than the cancer under study to determine cancer-specific survival and cancer-specific HRs. DATA SYNTHESIS: Results represent 189 877 white and 32 004 black patients with 14 different cancers. Compared with whites, blacks had an overall excess risk of death (HR, 1.16; 95% confidence interval [CI], 1.12-1.20). After correction for deaths due to other causes, the cancer-specific HR was 1.07 (95% CI, 1.02-1.13). Of the 14 cancers, blacks were at a significantly higher risk of cancer-specific death only for cancer of the breast, uterus, or bladder. CONCLUSIONS: Only modest cancer-specific survival differences are evident for blacks and whites treated comparably for similar-stage cancer. Therefore, differences in cancer biology between racial groups are unlikely to be responsible for a substantial portion of the survival discrepancy. Differences in treatment, stage at presentation, and mortality from other diseases should represent the primary targets of research and interventions designed to reduce disparities in cancer outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Unequal treatment: confronting racial and ethnic disparities in health care
(2003) · Choice Reviews Online · doi:10.5860/choice.40-5843 · Cited by 7,043
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
Modelling for Survival Data in Medical Research
(1995) · Technometrics · doi:10.1080/00401706.1995.10485920 · Cited by 2,145
Feinstein, A. R., Sosin, D. M., & Wells, C. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506203122504 · Cited by 1,544
Summing up: The Science of Reviewing Research
Wilkinson, I., Light, R. J., & Pillemer, D. B. (1987) · Journal of Educational Statistics · doi:10.2307/1164691 · Cited by 1,471
Racial Differences in the Treatment of Early-Stage Lung Cancer
Bach, P. B., Cramer, L. D., Warren, J. L., & Begg, C. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411606 · Cited by 994
Self-citationRacial and Ethnic Disparities in the Receipt of Cancer Treatment
Shavers, V. L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.5.334 · Cited by 950
The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer
Satariano, W. A., & Ragland, D. R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-2-199401150-00002 · Cited by 731
Eley, J. W. (1994) · JAMA · doi:10.1001/jama.1994.03520120057031 · Cited by 531
Breen, N., Wagener, D. K., Brown, M. L., Davis, W. W., & Ballard-Barbash, R. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1704 · Cited by 502
(1999) · National Academies Press eBooks · doi:10.17226/6377 · Cited by 366
Hoyert, D. L., Arias, E., Smith, B. L., Murphy, S. L., & Kochanek, K. D. (2001) · PubMed · Cited by 338
Freedman, L. S., Simon, R., Foulkes, M. A., Friedman, L., Geller, N. L., Gordon, D. J., & Mowery, R. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00048-8 · Cited by 314
Optenberg, S. A. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530200035033 · Cited by 253
Noncancer Deaths in White Adult Cancer Patients
Brown, B. W., Brauner, C., & Minnotte, M. C. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.979 · Cited by 252
Determinants of Black/White Differences in Colon Cancer Survival
Mayberry, R. M., Coates, R. J., Hill, H. A., Click, L. A., Chen, V. W., Austin, D. F., Redmond, C. K., Fenoglio-Preiser, C. M., Hunter, C. P., Haynes, M. A., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.22.1686 · Cited by 222
Effects of health insurance and race on breast carcinoma treatments and outcomes
Roetzheim, R. G., Gonzalez, E. C., Ferrante, J. M., Pal, N., Van Durme, D. J., & Krischer, J. P. (2000) · Cancer · doi:10.1002/1097-0142(20001201)89:11<2202::aid-cncr8>3.0.co;2-l · Cited by 216
Impact of Patient and Provider Characteristics on the Treatment and Outcomes of Colorectal Cancer
Hodgson, D. C., Fuchs, C. S., & Ayanian, J. Z. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.7.501 · Cited by 194
Breast Cancer: Factors Associated With Stage at Diagnosis in Black and White Women
Hunter, C. P., Redmond, C. K., Chen, V. W., Austin, D. F., Greenberg, R. S., Correa, P., Muss, H. B., Forman, M. R., Wesley, M. N., Blacklow, R. S., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.14.1129 · Cited by 190
Histological characteristics of breast carcinoma in blacks and whites.
Chen, V. W., Corréa, P., Kurman, R. J., Wu, X., Eley, J. W., Austin, D. F., Muss, H. B., Hunter, C. P., Redmond, C. K., & Sobhan, M. (1994) · PubMed · Cited by 183
Racial differences in colorectal cancer mortality
Marcella, S., & Miller, J. E. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00316-4 · Cited by 175
Differences in initial treatment patterns and outcomes of lung cancer in the elderly
Smith, T. J., Penberthy, L., Desch, C. E., Whittemore, M., Newschaffer, C., Hillner, B. E., McClish, D., & Retchin, S. M. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00496-3 · Cited by 172
Social factors, treatment, and survival in early-stage non-small cell lung cancer.
Greenwald, H. P., Polissar, N. L., Borgatta, E. F., McCorkle, R., & Goodman, G. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.11.1681 · Cited by 166
Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system
Dominitz, J. A., Samsa, G. P., Landsman, P., & Provenzale, D. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980615)82:12<2312::aid-cncr3>3.0.co;2-u · Cited by 165
Thompson, I. M., Tangen, C. M., Tolcher, A., Crawford, E. D., Eisenberger, M., & Moinpour, C. M. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.219 · Cited by 165
Wójcik, B. E., Spinks, M. K., & Optenberg, S. A. (1998) · Cancer · Cited by 154
Trends and Black/White Differences in Treatment for Nonmetastatic Prostate Cancer
Klabunde, C. N., Potosky, A. L., Harlan, L. C., & Kramer, B. S. (1998) · Medical Care · doi:10.1097/00005650-199809000-00006 · Cited by 152
Stage at presentation and survival of white and black patients with prostate carcinoma
Brawn, P. N., Johnson, E. H., Kuhl, D., Riggs, M. W., Speights, V. O., Johnson, C. F., Pandya, P. P., Lind, M. L., & Bell, N. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2569::aid-cncr2820710822>3.0.co;2-r · Cited by 148
Race and Differences in Breast Cancer Survival in a Managed Care Population
Yood, M. U., Johnson, C. C., Blount, A., Abrams, J. S., Wolman, E., McCarthy, B. D., Raju, U., Nathanson, D. S., Worsham, M. J., & Wolman, S. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1487 · Cited by 143
Comorbidity and breast cancer survival: A comparison between black and white women
West, D. W., Satariano, W. A., Ragland, D. R., & Hiatt, R. A. (1996) · Annals of Epidemiology · doi:10.1016/s1047-2797(96)00096-8 · Cited by 131
Dignam, J. J., Colangelo, L. H., Tian, W., Jones, J. M., Smith, R. E., Wickerham, D. L., & Wolmark, N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1933 · Cited by 131
Arbes, S. J., Olshan, A. F., Caplan, D. J., Schoenbach, V. J., Slade, G. D., & Symons, M. (1999) · Cancer Causes & Control · doi:10.1023/a:1008911300100 · Cited by 121
Howard, J. M., Hankey, B. F., Greenberg, R. S., Austin, D. F., Coma, P., Chen, V. W., & Durako, S. J. (1992) · Cancer · doi:10.1002/1097-0142(19920501)69:9<2349::aid-cncr2820690925>3.0.co;2-7 · Cited by 111
Diehr, P. H., Yergan, J., Chu, J. Y., Feigl, P., Glaefke, G., Moe, R. E., Bergner, M., & Rodenbaugh, J. (1989) · Medical Care · doi:10.1097/00005650-198910000-00005 · Cited by 102
Racial differences in endometrial cancer survival: The black/white cancer survival study
AHILL, H., WILLIAMELEY, J., CHARLAN, L., SGREENBERG, R., JBARRETTII, R., & WCHEN, V. (1996) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00341-9 · Cited by 90
Muss, H. B., Hunter, C. P., Wesley, M., Correa, P., Chen, V. W., Greenberg, R. S., Eley, J. W., Austin, D. F., Kurman, R. J., & Edwards, B. K. (1992) · Cancer · doi:10.1002/1097-0142(19921115)70:10<2460::aid-cncr2820701012>3.0.co;2-a · Cited by 88
Race and Outcomes: Is This the End of the Beginning for Minority Health Research?
Brawley, O. W., & Freeman, H. P. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1908 · Cited by 85
Leuprolide With and Without Flutamide in Advanced Prostate Cancer
Crawford, E. D., Blumenstein, B. A., Goodman, P. J., Davis, M. A., Eisenberger, M. A., McLeod, D. G., Spaulding, J. T., Benson, R. C., & Dorr, F. A. (1990) · Cancer · doi:10.1002/cncr.1990.66.s5.1039 · Cited by 84
Breast cancer: Is ethnicity an independent prognostic factor for survival?
Perkins, P., Cooksley, C. D., & Cox, J. D. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960915)78:6<1241::aid-cncr11>3.0.co;2-0 · Cited by 83
Differences in Cervical Cancer Mortality Among Black and White Women
Howell, E. A., CHEN, Y.-T., & CONCATO, J. (1999) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00334-8 · Cited by 81
Akerley, W., Moritz, T. E., Ryan, L. S., Henderson, W. G., & Zacharski, L. R. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410140063008 · Cited by 78
Black-White Differences in Stage-Specific Cancer Survival: Analysis of Seven Selected Sites
Regland, K. E., Selvin, S., & MERRILL, D. W. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115942 · Cited by 76
Dignam, J. J., Redmond, C. K., Fisher, B., Costantino, J. P., & Edwards, B. K. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970701)80:1<80::aid-cncr11>3.0.co;2-b · Cited by 73
Fowler, J. E., Bigler, S. A., BOWMAN, G., & KILAMBI, N. K. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67989-x · Cited by 73
Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation.
Heimann, R., Ferguson, D. J. P., Powers, C., Suri, D., Weichselbaum, R. R., & Hellmän, S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2329 · Cited by 70
Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541.
Roach, M., Cirrincione, C., Budman, D. R., Hayes, D., Berry, D. A., Younger, J., Hart, R., & Henderson, I. C. (1997) · PubMed · Cited by 68
Racial differences in the androgen/androgen receptor pathway in prostate cancer.
Pettaway, C. A. (1999) · PubMed · Cited by 65
Elevated levels of telomerase activity in malignant pheochromocytoma
Kubota, Y., Nakada, T., Sasagawa, I., Yanai, H., & Itoh, K. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980101)82:1<219::aid-cncr27>3.0.co;2-4 · Cited by 65
Racial differences in survival from gynecologic cancer
AMORGAN, M., Behbakht, K., Benjamin, I., BERLIN, M., AKING, S., & Rubin, S. C. (1996) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00342-0 · Cited by 62
Medicare Treatment Differences for Blacks and Whites
Lee, A. J., Gehlbach, S. H., Hosmer, D. W., Reti, M., & Baker, C. S. (1997) · Medical Care · doi:10.1097/00005650-199712000-00002 · Cited by 60
Disaggregating the effects of race on breast cancer survival.
Howard, D. L., Penchansky, R., & Brown, M. B. (1998) · PubMed · Cited by 58
Race, poverty, and survival in multiple myeloma
Savage, D. G., Lindenbaum, J., Ryzin, J. V., Struening, E. L., & Garrett, T. J. (1984) · Cancer · Cited by 58
Moody‐Ayers, S. Y., Wells, C. K., & Feinstein, A. R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.8.1109 · Cited by 56
The Value of the Aggregate Data Approach in Meta-Analysis with Time-to-Event Outcomes
Smith, C. T., Williamson, P. R., Khan, S. A., & Best, L. (2001) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/1467-985x.00207 · Cited by 49
Krongrad, A., Lai, H. C., Lamm, S. H., & Lai, S. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)65710-0 · Cited by 49
Modiano, M., Villar-Werstler, P., Crowley, J. J., & Salmon, S. E. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.974 · Cited by 34
Kimmick, G. G., Muss, H. B., Case, L. D., & Stanley, V. (1991) · Cancer · doi:10.1002/1097-0142(19910601)67:11<2850::aid-cncr2820671124>3.0.co;2-s · Cited by 33
Zagars, G. K., Pollack, A., & Pettaway, C. A. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00260-0 · Cited by 32
Graham, M. V., Geitz, L. M., Byhardt, R. W., Asbell, S., Roach, M., Urtasun, R. C., Curran, W. J., Lattin, P. B., Russell, A. H., & Cox, J. D. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.22.1731 · Cited by 31
Grigsby, P. W., Hall, L. E., Baker, S., & Pérez, C. A. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5974 · Cited by 28
Cervical cancer survival in a high risk urban population
Thoms, W. W., Unger, E. R., Johnson, P. R. A., Spann, C. O., Hunter, S. H., Smith, R., Horowitz, I., Icenogle, J. P., Vernon, S. D., & Reeves, W. C. (1995) · Cancer · doi:10.1002/1097-0142(19951215)76:12<2518::aid-cncr2820761217>3.0.co;2-# · Cited by 28
Race and Prognosis of Brain Tumor Patients Entering Multicenter Clinical Trials
Simpson, J. R., Scott, C., Rotman, M., et al. (1996) · American Journal of Clinical Oncology · doi:10.1097/00000421-199604000-00005 · Cited by 17
Overexpression of glut-1 glucose transporter in human breast cancer an immunohistochemical study
(1993) · doi:10.1002/1097-0142(19931115)72:10 · Cited by 1
Cited by
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
“There were 17% more lung cancer deaths in men (78,694) than in women (67,155) in 2017, but this pattern is projected to reverse by 2045 if current smoking trends continue.”
BackgroundSiegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Metadata
- Authors
- Bach, P. B.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-04-24
- Volume
- 287
- Issue
- 16
- Pages
- 2106
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2016725888
- Cited by
- 513
- References
- 65
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.